| __timestamp | Bausch Health Companies Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 11947000000 |
| Thursday, January 1, 2015 | 7853800000 | 12651000000 |
| Friday, January 1, 2016 | 7063000000 | 14481000000 |
| Sunday, January 1, 2017 | 6176000000 | 14710000000 |
| Monday, January 1, 2018 | 6029000000 | 16014000000 |
| Tuesday, January 1, 2019 | 6251000000 | 18067000000 |
| Wednesday, January 1, 2020 | 5778000000 | 30745000000 |
| Friday, January 1, 2021 | 6040000000 | 36445000000 |
| Saturday, January 1, 2022 | 5760000000 | 36022000000 |
| Sunday, January 1, 2023 | 6198000000 | 34313000000 |
| Monday, January 1, 2024 | 36351000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding financial health is crucial. Over the past decade, Bristol-Myers Squibb Company has consistently outperformed Bausch Health Companies Inc. in terms of gross profit. From 2014 to 2023, Bristol-Myers Squibb's gross profit surged by nearly 187%, peaking in 2021 with a remarkable $36 billion. In contrast, Bausch Health's growth was more modest, with a peak in 2015 at approximately $7.9 billion, reflecting a 31% increase from 2014.
Bristol-Myers Squibb's strategic acquisitions and robust product pipeline have fueled its financial ascent, particularly evident in the 2020-2021 period. Meanwhile, Bausch Health's steady performance highlights its resilience amidst market challenges. This comparative analysis underscores the importance of strategic innovation and market adaptation in achieving financial success in the pharmaceutical sector.
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Key Insights on Gross Profit: Novartis AG vs Bausch Health Companies Inc.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Zoetis Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Exelixis, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Bausch Health Companies Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown